← Leaderboards
Carol Wallace
University Of Washington
$11,592
Attributed
$11,592
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$11,592 · 2
By mechanism
M01$11,592 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Janis L Abkowitz$28,579,442
- Edward A Clark$26,060,534
- Christopher B Wilson$12,673,338
- Kenneth Kaushansky$9,324,127
- Lisa M Frenkel$29,105,317
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectJuvenile Rheumatoid ArthritisClinical ResearchHuman Therapy EvaluationAntiarthritic AgentSkeletal Disorder ChemotherapyCytokine ReceptorsClinical Trial Phase IImmunopathology ChemotherapyImmunotherapyChild (0-11)PediatricsPharmacokineticsTumor Necrosis Factor AlphaDrug Administration Rate /Duration
Grant awards (6)
TREATMENT WITH TNFR-FC CLINICAL TRIALS$0
M01 · FY2002 · RR
TREATMENT WITH TNFR-FC CLINICAL TRIALS$0
M01 · FY2001 · RR
SAFETY POPULATION PHARMACOKINETICS AND EFFICACY OF TNFR/FC IN JRA$3,864
M01 · FY2000 · RR
SAFETY POPULATION PHARMACOKINETICS AND EFFICACY OF TNFR/FC IN JRA$3,864
M01 · FY2000 · RR
OPEN LABEL EXTENSION TREATMENT W/ TNFR:FC FOR PARTICIPATING PATIENTS$3,864
M01 · FY2000 · RR
TREATMENT WITH TNFR-FC CLINICAL TRIALS$0
M01 · FY2000 · RR